Steal This Newsletter June 18 '26

Mass Tort and Personal Injury Update | June 18, 2026 Edition

By Michael Stanisci, MassTortMichael

A note to law firms: this newsletter is built to be shared. Take it. Put your logo on it. Send it to your clients, your past clients, and your referral network

. All I ask is that you keep the attribution to MassTortMichael. The people who need this information are the ones who never see it. You can be the one who shows them.

1. Opening Note from Michael

I have been doing this long enough to know that most weeks bring small, steady movement. This week brought a shock. On June 15, the judge running the Depo-Provera brain tumor litigation announced that Pfizer and plaintiffs' lawyers had reached a global settlement framework, before a single Daubert hearing, before a single bellwether trial.

That almost never happens this early in a case. I will walk through what it means and what it does not mean yet, because the headlines are already running ahead of the facts.

This is also a week where the gap between states is the story. In New York and New Jersey, institutional abuse cases are reaching settlements and surviving appeals. In Pennsylvania, survivors are still waiting on a lookback window that has been promised, voted on, and stalled for nearly a decade. Same country, same kind of harm, very different paths to justice. I think that contrast matters for how we think about the work in front of us.

This is the kind of moment our work exists for. Numbers and dockets matter, but they sit on top of real families having the worst day of their lives. Let's help more people.

2. Fast Facts This Week

• Pfizer and plaintiffs' counsel told the court on June 15 that they have a global settlement framework for the Depo-Provera meningioma litigation, and the judge postponed the June Daubert hearing to July 27 while the deal is finalized [1][2].

• There are roughly 5,500 to 5,549 Depo-Provera cases pending in the federal MDL in the Northern District of Florida, with hundreds more in state courts in Delaware, New York, California, and elsewhere [3][4].

• The first federal NEC baby formula bellwether trial is set for July 6, 2026, in Chicago federal court, involving a baby named Daniel who died days after birth [5][6].

• A Missouri appeals court upheld the full $495 million verdict against Abbott in the Gill v. Abbott NEC case, a result lawyers say strengthens the playbook for the families still waiting their turn [7].

• On June 4, the federal panel created a brand-new MDL, number 3180, for Dupixent lawsuits alleging the drug caused or worsened a rare blood cancer, and sent the cases to a judge in New Jersey [8].

• The Department of Justice moved this week to block a NAACP lawsuit accusing Elon Musk's xAI of illegally polluting Memphis neighborhoods with unpermitted gas turbines, arguing the case threatens national security [9][10].

• The Diocese of Camden in southern New Jersey finalized a $180 million settlement in February for roughly 300 clergy abuse survivors, while Pennsylvania still has no lookback window of any kind for survivors whose claims already expired [11][12].

• California, Texas, and Florida remain the three states with the highest raw number of traffic deaths in the country, a pattern that has held for over a decade [13][14].

3. Key Mass Tort Spotlights

Spotlight 1: Depo-Provera and the Settlement Nobody Expected (MDL 3140)

Picture a woman who got her birth control shot every three months for years because it was simple and it worked. Then one day she gets headaches that will not quit, or her vision starts doing strange things, and a scan turns up a tumor sitting on the lining of her brain. That is the story behind thousands of Depo-Provera lawsuits. The drug, made by Pfizer, has been linked to meningioma, a usually non-cancerous brain tumor that can still require surgery and leave lasting damage depending on where it grows.

For most of this year, the case has moved on a fast track. The FDA approved a new label warning about meningioma risk in December 2025, which weakened Pfizer's argument that federal law shielded it from blame [3]. Roughly 5,500 cases piled into the MDL before Judge M. Casey Rodgers in the Northern District of Florida, and the court scheduled a major Daubert hearing for late June to decide whether the plaintiffs' scientific experts could even reach a jury [1][3].

Then, on June 15, everything paused. Judge Rodgers issued an order saying the parties had reached a global settlement framework and were working to finalize the details [2]. One plaintiffs' attorney called it a "rocket docket," noting how unusual it is to see a deal take shape before any bellwether trial, before any ruling on Pfizer's preemption defense, and before any expert has testified [2]. The June hearings were postponed to late July while the lawyers write up the agreement.

Evaluation snapshot.

• Plaintiff Numerosity: High and still growing, more than 1,700 new cases filed in just the weeks before the settlement news [4].

• Defendant Viability: Pfizer is large and solvent, well able to fund a resolution.

• Financial Viability: It is believed that the settlement will be funded without threatening Pfizer's ongoing operations, though no dollar figures have been released [4].

• Scientific Viability: Studies linking high-dose progestins to meningioma go back decades, and the new FDA label gave that science institutional backing [3].

• Time to Resolution: Once unusually fast for a pharmaceutical MDL. Now paused while the deal is papered. It is our understanding that research is still leading toward final terms, not a finished agreement [2].

• Venue of MDL: Northern District of Florida, Judge M. Casey Rodgers [3].

• Bellwether Results: None occurred. The December 7 Blonski trial date has been vacated pending settlement [2].

• Daubert and Frye: The June 24 to 26 hearing was postponed to July 27 [2].

• State of Litigation: Settlement negotiation phase, a rare and early stage for this to happen.

What firms should consider next. Do not stop screening cases because a settlement is in the works. Settlements like this typically need a claims process, and women who have not yet come forward will still need a lawyer to help them file. Keep your screening simple: at least one injection of Depo-Provera (mixed use with generics might be alright), plus an image-confirmed meningioma diagnosis [4]. Watch for the formal settlement terms before promising clients any number, since early estimates online range wildly and most are guesses.

Spotlight 2: NEC Baby Formula, A Trial Seven Years in the Making (MDL 3026)

A mother holds her premature baby in the NICU, grateful the infant survived the early delivery, only to watch necrotizing enterocolitis tear through the baby's intestines days later. That is necrotizing enterocolitis, or NEC, a disease that can kill or permanently injure premature infants. The lawsuits allege that cow's milk-based formulas made by Abbott and Mead Johnson raised that risk in fragile babies and that the companies never warned anyone.

For years the federal case, MDL 3026 before Judge Rebecca Pallmeyer in the Northern District of Illinois, could not get a bellwether trial across the finish line. Cases kept getting dismissed before trial on expert and evidence disputes. Meanwhile, state courts told a very different story. A Missouri jury awarded $495 million in 2024, an Illinois jury awarded $60 million, and a more recent Abbott verdict added $70 million, for a combined total approaching $630 million in state court verdicts [6][7].

That changed on May 8, when Judge Pallmeyer rejected Mead Johnson's bid to throw out the case before trial, clearing the path for the first federal bellwether [6]. That trial, involving a baby named Daniel who died just days after birth, is set to begin July 6, 2026, in Chicago [5]. A second trial, involving a California family whose daughter survived NEC with permanent injuries, follows on August 10 [6]. A Missouri appeals court also just upheld the full $495 million verdict against Abbott, rejecting the company's challenge to the causation evidence and the punitive damages [7].

Evaluation snapshot.

• Plaintiff Numerosity: Roughly 798 cases in the federal MDL, with 600 to 700 more in state courts [6][7].

• Defendant Viability: Both Abbott and Mead Johnson are large, well-funded companies.

• Financial Viability: Strong on paper, though sustained losses at trial could change the calculus around settlement.

• Scientific Viability: Strengthened by the appellate win in Gill v. Abbott, which found the evidence sufficient for a jury to find causation [7].

• Time to Resolution: It is believed that a plaintiff win at the July 6 trial could accelerate settlement talks, though that is conjecture until a verdict is in.

• Venue of MDL: Northern District of Illinois, Judge Rebecca Pallmeyer [6].

• Bellwether Results: None yet in the federal MDL, three straight state court verdicts for plaintiffs totaling roughly $630 million [6][7].

• Daubert and Frye: A central battleground for years, with multiple bellwethers dismissed on expert challenges before this trial survived [6].

• State of Litigation: Litigation phase, heading into its most important trial to date.

What firms should consider next. July 6 and August 10 are dates to circle. A plaintiff win in either trial is likely to draw a wave of new filings and could shift the settlement posture for everyone with a pending case. If you have files that were declined under older, stricter screening criteria, this is a good moment to take a second look, especially for babies born significantly premature who were fed cow's milk-based formula or fortifier in the NICU.

Spotlight 3: Dupixent, the Brand-New One to Watch (MDL 3180)

A man treats his asthma and a stubborn rash with Dupixent for months, the same drug doctors call a wonder treatment for eczema and asthma. Instead of clearing up, his rash gets worse, and doctors eventually diagnose cutaneous T-cell lymphoma, a rare cancer of the skin's immune cells. That is the claim now sitting at the center of a brand-new federal litigation.

On June 4, the Judicial Panel on Multidistrict Litigation created MDL No. 3180 for Dupixent lawsuits and sent the cases to Judge Zahid N. Quraishi in the District of New Jersey [8]. At the time of transfer, only 15 lawsuits were pending across 12 federal districts, with seven more expected to follow [8]. The claims allege that Sanofi and Regeneron knew or should have known about a lymphoma risk as far back as 2018 and failed to warn doctors and patients [12].

The science here is young but moving. One matched-cohort study found a 4.59 times higher relative risk of this lymphoma among patients on the drug compared to non-users, and the FDA added Dupixent to its list of potential serious safety signals in March 2025 after more than 300 reports came in [12]. None of that proves the drug caused any one person's cancer, and no settlements or verdicts exist yet. What is not in dispute is the size of the exposed population. Dupixent sales are projected to hit roughly $20 billion in 2026, more than a third of Sanofi's total revenue [4].

Evaluation snapshot.

• Plaintiff Numerosity: Small today, only about 15 known cases, but the drug is used by a very large patient population [8][4].

• Defendant Viability: Sanofi and Regeneron are both large, financially strong pharmaceutical companies.

• Financial Viability: Strong defendants, and a drug this profitable gives both sides reason to litigate carefully.

• Scientific Viability: Developing. It is our understanding that research is still leading toward, not settled on, causation, though the relative risk findings are notable [12].

• Time to Resolution: Long. This MDL is just weeks old. Bellwether trials are years away.

• Venue of MDL: District of New Jersey, Judge Zahid N. Quraishi [8].

• Bellwether Results: None.

• Daubert and Frye: Not yet reached. The case is still in its earliest organizational stage.

• State of Litigation: Emerging phase, the lowest-cost, highest-uncertainty window in the life of a case.

What firms should consider next. This is the kind of case where patience pays. Cost per client is lower now precisely because the science has not been tested in court. If your firm has the risk tolerance for an emerging case, start identifying patients with a CTCL, mycosis fungoides, or Sezary syndrome diagnosis who used Dupixent for eczema, asthma, or another inflammatory condition, and start building a clean medical timeline now while records are easiest to get.

Spotlight 4: AI Data Centers, A New Kind of Mass Tort Story

In Southaven, Mississippi, just over the state line from Memphis, there is a power plant that nobody approved. Elon Musk's company xAI built it to run dozens of gas turbines that keep its Colossus data centers cool and online, the same data centers that power the Grok chatbot. The turbines sit near homes, schools, and churches in a community that is majority Black. Thermal images showed the turbines running for months without the air permits the Clean Air Act requires, and the company's local pollution numbers are estimated to rival those of Memphis International Airport [15][16].

The NAACP sued in April under the Clean Air Act's citizen-suit provision, the same legal tool communities have used for fifty years when regulators will not act [15]. xAI responded by adding six more turbines instead of fixing the permit problem, prompting the NAACP to seek an emergency injunction in May [15]. Then, on June 16, the Department of Justice did something its own enforcement lawyers called remarkable: it moved to intervene on the side of the polluter, arguing the lawsuit threatens national security by limiting power to an AI data center [9][10][17].

This is not an isolated fight. In Oregon, Amazon agreed in March to pay $20.5 million to settle claims that its data centers worsened nitrate contamination in groundwater that more than 600 households already could not safely drink [11]. The legal theory there, that evaporative cooling towers concentrate existing pollution rather than just using water, is now being tested in other agricultural, water-stressed regions across the country [11]. Meta has faced similar water contamination questions in Georgia. None of this fits neatly into an existing mass tort category yet, but the pattern across these cases, environmental harm tied to AI infrastructure built at speed with limited public input, is becoming a story plaintiffs' firms should know.

Evaluation snapshot.

• Plaintiff Numerosity: Currently organized around discrete communities (Memphis and Southaven, Morrow County, Oregon, and similar sites), not yet a single consolidated mass tort.

• Defendant Viability: Varies by company, but xAI, Amazon, and Meta are all well-capitalized.

• Financial Viability: Strong defendants, though the Amazon settlement shows real money can change hands even without a final court ruling on liability [11].

• Scientific Viability: The "concentrator theory" behind the water cases is genuinely novel and untested on the merits, no court has yet ruled on whether cooling-tower discharge counts as regulated waste [11].

• Time to Resolution: Early and unpredictable. The DOJ's intervention in the xAI case adds real uncertainty about how fast, or how far, citizen suits can go right now [9].

• Venue of MDL: No MDL exists. Cases are proceeding individually in federal courts in Mississippi, Oregon, and elsewhere [9][11].

• Bellwether Results: None. The Amazon Oregon case settled before any merits ruling [11].

• Daubert and Frye: Not yet reached in any of these matters.

• State of Litigation: Emerging, and unusually contested at the political level given the DOJ's involvement.

What firms should consider next. This is not yet a personal injury intake category, it is closer to environmental and toxic tort territory, often led by advocacy groups and environmental firms rather than mass tort shops. But if your firm has community relationships in a place with a new or proposed data center, especially one near agricultural land or already-stressed water systems, pay attention. Residents near these facilities are dealing with noise, air quality, and water concerns right now, and many do not know there is a legal path to address it.

Spotlight 5: Institutional Sex Abuse, A Tale of Three States

Survivors of childhood sexual abuse often carry their story alone for decades before they ever say it out loud. The laws that let them finally bring a civil case matter enormously, and right now New York, New Jersey, and Pennsylvania are living three very different versions of that story.

New York. The Child Victims Act opened a lookback window from August 2019 to August 2021 that drew more than 10,000 lawsuits against churches, schools, camps, and other institutions [18]. A separate Adult Survivors Act window for adult assault survivors ran from November 2022 to November 2023. Both windows are now closed, but the cases they generated are still working through the courts, and verdicts are starting to land. In February, an appellate court affirmed a $5 million jury verdict in Quentin v. Knox, a case involving abuse that happened in the 1960s, more than half a century before the lawsuit was filed [18]. Right now, state lawmakers are also pushing a bill, S9848/A8635B, to stop courts from dismissing Child Victims Act and Adult Survivors Act cases over minor factual gaps, like a survivor not remembering an exact date, something advocates say has wrongly knocked out more than 1,800 cases [19][20].

New Jersey. New Jersey's own lookback window ran from December 2019 to December 2021, and the state's permanent statute of limitations now extends to age 55. The fallout is still landing on dioceses. In February, the Diocese of Camden in southern New Jersey finalized a $180 million settlement covering roughly 300 survivors, on top of an $87.5 million settlement it had already paid in 2022 [11][21]. Up the road, the Diocese of Trenton is fighting its own insurer in federal court over coverage for more than 550 abuse claims and over 200 lawsuits, with the diocese arguing the dispute is premature while the underlying abuse cases are still in discovery [21]. New Jersey survivors largely have their day in court. What they are fighting now is how, and how much, institutions actually pay.

Pennsylvania. This is the state still stuck. Pennsylvania extended its statute of limitations to age 55 back in 2019, the same year New York and New Jersey opened their windows, but unlike its neighbors, it has never passed a lookback window for survivors whose claims had already expired. Because Pennsylvania requires a constitutional amendment for that kind of retroactive fix, not just a regular statute, the bill has to pass two separate legislative sessions before voters even get a say. Versions of this proposal have passed with bipartisan support in 2019, 2021, and 2023, and have died anyway, sometimes on a technicality. At an April 23 hearing, one survivor put it plainly: "We've never had any justice. We've never had a window to justice. It hides the predators and it protects the institutions that enable the predators" [22][23]. Lawmakers are trying again this session with House Bill 462, a straightforward statutory window that could pass and take effect quickly, and House Bill 464, the constitutional amendment route [24].

What firms should consider next. In New York and New Jersey, the work now is largely about identifying institutions with deep pockets and pursuing settlements, plus watching how courts treat procedural challenges in already-filed cases. In Pennsylvania, the most useful thing a firm can do may be civic rather than legal: track HB 462 and HB 464 closely, because if either passes, a flood of previously time-barred Pennsylvania survivors will suddenly have a short window to act, and firms that are ready will serve them better than firms scrambling to catch up.

If anything in this section affects you personally, please know that support exists. The National Sexual Assault Hotline, run by RAINN, is available at 1-800-656-4673, and speaking with a licensed attorney about your specific situation is always a reasonable next step, whenever you are ready.

4. Personal Injury Watchlist

• Auto accident trends, by the numbers. California, Texas, and Florida have ranked as the three states with the highest total number of traffic deaths for over a decade, a pattern driven mainly by population and vehicle miles traveled rather than any single cause [13][14]. Georgia and North Carolina round out a current top five [13].

• I-95 Stafford County, Virginia bus crash. On May 29, a charter bus failed to slow for a highway work zone and struck multiple vehicles, killing five people, including two children, and sending 44 more to area hospitals in what officials declared a mass casualty incident [25][26]. The driver faces five counts of involuntary manslaughter, and the NTSB is investigating [25].

• Texas severe storm disaster declaration. On June 15, Governor Abbott issued a disaster proclamation covering more than 60 Texas counties after a severe storm system beginning June 14 brought flash flooding, large hail, and tornado threats, causing widespread property damage across the southern and eastern parts of the state [27].

• Recall watch. The CPSC has been issuing recalls weekly, including bicycle helmets that failed federal safety testing and coolers with a choking hazard from a detachable latch magnet [28][29]. Recalls are often the earliest public signal of a future product liability case, so it is worth building a habit of checking them regularly.

5. Practical Outreach Angles for Firms

Marketing is what reaches the people who do not yet know they have a claim. Pairing it with the relationships you already have multiplies what each marketing dollar does.

• Mine your closed PI and family law files. A short letter or email about Depo-Provera, NEC, or Dupixent can surface claims sitting quietly in files you already have.

• Add one question to intake. Ask every new client: has anyone in your family been diagnosed with a brain tumor, a rare cancer, or a serious complication after using a prescription drug or medical product? You may be surprised what surfaces.

• Build local relationships near data center projects. If a data center is proposed or already operating near your market, residents dealing with noise, water, or air concerns may not know there is a legal path forward. A local presence built on trust, not ads, tends to work best here.

• Watch Harrisburg, not just the courthouse. For Pennsylvania institutional abuse cases, the next major development may be legislative, not judicial. Firms that track HB 462 and HB 464 now will be ready the moment a window opens.

• Send this newsletter. That is the whole idea behind the name. Brand it, adapt it, keep the attribution, and get it in front of your list this week.

We are all better together. Follow your state bar's advertising and solicitation rules as you go, and nothing here is legal advice. Anyone with a potential claim should talk to a licensed attorney about their own situation.

6. From Michael

This is where I usually try to bring it back to something personal, so here it is. A lot of my work right now is sitting down with firms on the operations side of mass tort, not just the marketing side. I help firms build out motor vehicle accident acquisition the right way, since auto cases are still the steady backbone of a lot of practices even while mass torts get the headlines. I help with case workup, so files move faster and cleaner from intake to settlement. I help firms find access to capital when a good case load outpaces cash flow, which happens to good firms more often than people admit. And I help firms actually implement AI in their practice, not as a buzzword, but as a real tool for intake triage, document review, and client communication that frees up your staff for the parts of the job that need a human.

If any of that sounds useful, reach out. I mean that simply. Email me at michael@masstortmichael.com or text me directly at 908-548-5378.

Steady as we go. Let's keep helping more people than ever, because we are #BetterTogether.

– Michael

7. Contact Michael Stanisci — MassTortMichael

• If you are a potential claimant: I can help connect you with the right law firm for your situation, at no cost to you.

• If you are an attorney or legal service provider: I work end to end, on motor vehicle accident acquisition, case workup, access to capital, and implementing AI the right way inside your practice.

• Email: michael@masstortmichael.com

• Call or text: 908-548-5378

• Web: https://www.masstortmichael.com/

• Social: @MassTortMichael and @michaeljstanisci across LinkedIn, X, Instagram, Facebook, YouTube, Threads, and TikTok

8. Citations

1. AboutLawsuits, Depo-Provera causation hearings rescheduled — https://www.aboutlawsuits.com/depo-provera-lawsuit/hearings-evidence-depo-provera-causes-meningioma-brain-tumors-june-2026/

2. Robert King Law Firm, Depo-Provera Settlement Negotiations press release, June 2026 — https://www.robertkinglawfirm.com/press-releases/depo-provera-settlement-negotiations-attorney-shares-insights-on-the-recent-announcement/

3. MDL Update, MDL 3140 Depo-Provera case page — https://mdlupdate.com/mdl/3140-depo-provera/

4. Drugwatch, Depo-Provera Lawsuit, June 2026 update — https://www.drugwatch.com/depo-provera/lawsuit/

5. BusinessWire, Trial Set in NEC Multidistrict Litigation Against Mead Johnson, March 2026 — https://www.businesswire.com/news/home/20260305466625/en/Trial-Set-in-NEC-Multidistrict-Litigation-Against-Reckitt-Benckisers-Mead-Johnson-Led-by-Levin-Papantonio

6. Lawsuit Information Center, NEC Baby Formula Lawsuit, June 2026 update — https://www.lawsuit-information-center.com/nec-baby-formula-lawsuits.html

7. Robert King Law Firm, NEC Baby Formula Lawsuit, June 2026 update — https://www.robertkinglawfirm.com/mass-torts/nec-baby-formula-lawsuit/

8. AboutLawsuits, Dupixent Lawsuit, MDL 3180 established June 4, 2026 — https://www.aboutlawsuits.com/dupixent-lawsuit/

9. Washington Post, Justice Department aims to block lawsuit against xAI's polluting data centers, June 16, 2026 — https://www.washingtonpost.com/technology/2026/06/16/justice-department-aims-block-lawsuit-against-xai-polluting-data-centers/

10. qz.com, DOJ moves to dismiss NAACP Clean Air Act lawsuit against xAI — https://qz.com/trump-doj-naacp-xai-clean-air-act-lawsuit-memphis-061726

11. Rain Intelligence, Data-Center Water Pollution and Amazon's $20.5M Nitrate Settlement, June 2026 — https://www.rainintelligence.com/blog/data-center-water-pollution-litigation

12. TorHoerman Law, Dupixent Lawsuit, 2026 — https://www.torhoermanlaw.com/dupixent-lawsuit/

13. AOL/Moneywise, These 5 states had the most traffic deaths in 2025 — https://www.aol.com/finance/5-states-had-most-traffic-170000492.html

14. PRLog/Kryder Law Group, America's Deadly Roads Are Not Getting Safer (FARS data, 2013-2022) — https://markets.financialcontent.com/clarkebroadcasting.mycentraloregon/article/prlog-2024-4-24-americas-deadly-roads-are-not-getting-safer

15. Earthjustice, NAACP Asks Court for Emergency Action to Stop Illegal Air Pollution from xAI's Data Center Power Plant — https://earthjustice.org/press/2026/naacp-asks-court-for-emergency-action-to-stop-illegal-air-pollution-from-xais-data-center-power-plant

16. Democracy Now, "Colossus Failure": Elon Musk's Data Centers Face Lawsuit for Polluting Black Neighborhoods in Memphis — https://www.democracynow.org/2026/4/22/memphis_xai_data_center_pollution_keshaun

17. Earthjustice, Trump Administration Attempts Massive Power Grab in Defense of Musk's xAI — https://earthjustice.org/press/2026/trump-administration-attempts-massive-power-grab-in-defense-of-musks-xai

18. JTNY Law, $5M Abuse Verdict Affirmed, NY Survivors Act, February 2026 — https://jtnylaw.com/2026/02/survivors-act-5-million-verdict-childhood-sexual-abuse-ny/

19. City & State New York, Will a remedy bill for sex-abuse cases stall in the Assembly again?, May 2026 — https://www.cityandstateny.com/policy/2026/05/will-remedy-bill-sex-abuse-cases-stall-assembly-again/413858/

20. My Champlain Valley/Nexstar, Will New York lawmakers prevent thousands of abuse cases from being dismissed? — https://www.mychamplainvalley.com/news/local-news/new-york/ny-law-would-change-time-limits-for-sexual-abuse-lawsuits-against-the-state/

21. Lawsuit Information Center, New Jersey Sex Abuse Lawsuit Settlements, June 2026 — https://www.lawsuit-information-center.com/new-jersey-sex-abuse-lawsuits-and-settlements.html

22. Pennsylvania Capital-Star, Victims, advocates urge action on lookback window for abuse victims in Pa., April 2026 — https://penncapital-star.com/civil-rights-social-justice/victims-advocates-urge-action-on-lookback-window-for-abuse-victims-in-pa/

23. fox43.com, Childhood sex abuse survivors call for justice, statute of limitations reform in Pennsylvania, April 2026 — https://www.fox43.com/article/news/politics/child-sex-abuse-statute-of-limitations-pennsylvania-lara-st-john-marci-hamilton-nate-davidson/521-7d8b99f6-770e-4ccb-b70a-0b2c033d44cf

24. Cordisco & Saile LLC, PA Sex Abuse Statute of Limitations: 2026 Update — https://www.cordiscosaile.com/blog/pa-sex-abuse-statute-of-limitations-2026-update/

25. WTOP, 5 dead, dozens injured in crash on I-95 southbound in Stafford Co., May 2026 — https://wtop.com/stafford-county/2026/05/5-dead-dozens-injured-in-crash-on-i-95-southbound-in-stafford-co/

26. NBC4 Washington, 5 dead, 44 taken to hospitals after I-95 bus crash in Stafford — https://www.nbcwashington.com/news/local/northern-virginia/stafford-crash-closes-southbound-i-95-at-mile-marker-146/4110033/

27. Office of Texas Governor Greg Abbott, Severe Storm Disaster Proclamation, June 2026 — https://gov.texas.gov/news/post/governor-abbott-issues-severe-storm-disaster-proclamation-in-june-2026

28. CPSC.gov, Recalls and Product Safety Warnings — https://www.cpsc.gov/Recalls

29. ConsumerAffairs, Consumer product safety recall roundup for June 5, 2026 — https://www.consumeraffairs.com/news/consumer-product-safety-recall-roundup-for-june-5-2026-060526.html

9. Copyright and Sharing

Copyright © 2026 Michael Stanisci, Nisci Consulting LLC and MassTortMichael. You are encouraged to share or adapt this newsletter within your own practice with attribution to MassTortMichael.

This newsletter is general information, not legal advice. Litigation facts change quickly, and case counts, dates, and settlement terms reflect the sources cited as of June 18, 2026. Eligibility criteria and filing deadlines vary by state and by case. Anyone with a potential claim, or any concern raised in this newsletter, should consult a licensed attorney or the appropriate support resource about their specific situation.